FDA Approved: DILANTIN-125 — Supplemental Application (Viatris Specialty LLC)

View source ↗

Summary

Supplemental NDA application for DILANTIN-125 (phenytoin) by Viatris Specialty LLC, likely involving labeling changes or addition of a dosage strength.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• DILANTIN-125 (phenytoin)

Snippet

SUPPL AP for DILANTIN-125 (PHENYTOIN)